Andreas Mitsis, Panayiotis Avraamides, John Lakoumentas, Michaela Kyriakou, Stefanos Sokratous, Georgia Karmioti, Michail Drakomathioulakis, Konstantinos C Theodoropoulos, Athina Nasoufidou, Alexandros Evangeliou, Vassilios Vassilikos, Nikolaos Fragakis, Antonios Ziakas, Stergios Tzikas, George Kassimis
After a myocardial infarction, the inflammatory response is connected to major adverse outcomes such as ischemia-reperfusion injury, adverse cardiac remodeling, infarct size and poor prognosis. INFlammatIoN amI sTudY (INFINITY) is a multicenter, prospective, observational, cohort study designed to investigate the prognostic role of the cytokines IL-6, IL-10, IL-18 and IL-17 and the adipokines leptin, apelin and chemerin in patients with acute coronary syndrome. The study will test if these inflammatory biomarkers reflect different clinical manifestations of coronary artery disease and have a prognostic role in a 6-month follow-up period...
January 18, 2024: Biomarkers in Medicine